Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-14-007655
Filing Date
2014-08-01
Accepted
2014-08-01 17:04:26
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2188910
2 filename2.htm EX-3 170654
3 filename3.htm EX-10 315388
4 filename4.htm EX-10 242173
5 filename5.htm EX-10 5373
6 filename6.htm EX-21 3286
7 GRAPHIC g744944g07l04.jpg GRAPHIC 3112
8 GRAPHIC g744944g10r60.jpg GRAPHIC 11585
9 GRAPHIC g744944g28c05.jpg GRAPHIC 26063
10 GRAPHIC g744944g31m63.jpg GRAPHIC 26746
11 GRAPHIC g744944g36b24.jpg GRAPHIC 71190
12 GRAPHIC g744944g37c46.jpg GRAPHIC 39944
13 GRAPHIC g744944g43r71.jpg GRAPHIC 65013
14 GRAPHIC g744944g51c45.jpg GRAPHIC 25294
15 GRAPHIC g744944g56o31.jpg GRAPHIC 3206
16 GRAPHIC g744944g58f44.jpg GRAPHIC 4025
17 GRAPHIC g744944g73t13.jpg GRAPHIC 46473
18 GRAPHIC g744944g90m14.jpg GRAPHIC 22992
  Complete submission text file 0000950123-14-007655.txt   3404786
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-00717 | Film No.: 141010764
SIC: 2834 Pharmaceutical Preparations